Bifogade filer
PDF
Kurs
+3,38%
Likviditet
0,05 MSEK
Kalender
| Est. tid* | ||
| 2025-11-28 | 08:30 | Kvartalsrapport 2025-Q3 |
| 2025-08-29 | 08:30 | Kvartalsrapport 2025-Q2 |
| 2025-06-16 | N/A | X-dag ordinarie utdelning CHOSA 0.00 SEK |
| 2025-06-13 | N/A | Årsstämma |
| 2025-05-30 | 08:30 | Kvartalsrapport 2025-Q1 |
| 2025-02-28 | - | Bokslutskommuniké 2024 |
| 2024-11-11 | - | Kvartalsrapport 2024-Q3 |
| 2024-10-23 | - | Extra Bolagsstämma 2024 |
| 2024-08-30 | - | Kvartalsrapport 2024-Q2 |
| 2024-05-31 | - | Årsstämma |
| 2024-05-31 | - | Kvartalsrapport 2024-Q1 |
| 2024-05-17 | - | X-dag ordinarie utdelning CHOSA 0.00 SEK |
| 2024-02-29 | - | Bokslutskommuniké 2023 |
| 2023-11-10 | - | Kvartalsrapport 2023-Q3 |
| 2023-08-31 | - | Kvartalsrapport 2023-Q2 |
| 2023-05-29 | - | X-dag ordinarie utdelning CHOSA 0.00 SEK |
| 2023-05-26 | - | Årsstämma |
| 2023-05-05 | - | Kvartalsrapport 2023-Q1 |
| 2023-02-27 | - | Bokslutskommuniké 2022 |
| 2023-01-11 | - | Extra Bolagsstämma 2022 |
| 2022-11-11 | - | Kvartalsrapport 2022-Q3 |
| 2022-08-26 | - | Kvartalsrapport 2022-Q2 |
| 2022-05-19 | - | X-dag ordinarie utdelning CHOSA 0.00 SEK |
| 2022-05-18 | - | Årsstämma |
| 2022-05-05 | - | Kvartalsrapport 2022-Q1 |
| 2022-02-11 | - | Bokslutskommuniké 2021 |
| 2021-11-12 | - | Kvartalsrapport 2021-Q3 |
| 2021-08-27 | - | Kvartalsrapport 2021-Q2 |
| 2021-05-20 | - | X-dag ordinarie utdelning CHOSA 0.00 SEK |
| 2021-05-19 | - | Årsstämma |
| 2021-05-05 | - | Kvartalsrapport 2021-Q1 |
| 2021-02-12 | - | Bokslutskommuniké 2020 |
| 2020-11-13 | - | Kvartalsrapport 2020-Q3 |
| 2020-08-28 | - | Kvartalsrapport 2020-Q2 |
| 2020-05-13 | - | X-dag ordinarie utdelning CHOSA 0.00 SEK |
| 2020-05-12 | - | Årsstämma |
| 2020-05-05 | - | Kvartalsrapport 2020-Q1 |
| 2020-02-11 | - | Bokslutskommuniké 2019 |
| 2019-11-15 | - | Kvartalsrapport 2019-Q3 |
| 2019-09-25 | - | Extra Bolagsstämma 2019 |
| 2019-08-30 | - | Kvartalsrapport 2019-Q2 |
| 2019-05-10 | - | X-dag ordinarie utdelning CHOSA 0.00 SEK |
| 2019-05-09 | - | Årsstämma |
| 2019-05-08 | - | Kvartalsrapport 2019-Q1 |
| 2019-02-12 | - | Bokslutskommuniké 2018 |
| 2018-11-16 | - | Kvartalsrapport 2018-Q3 |
| 2018-08-31 | - | Kvartalsrapport 2018-Q2 |
| 2018-05-11 | - | X-dag ordinarie utdelning CHOSA 0.00 SEK |
| 2018-05-09 | - | Årsstämma |
| 2018-05-09 | - | Kvartalsrapport 2018-Q1 |
| 2018-02-13 | - | Bokslutskommuniké 2017 |
| 2017-11-03 | - | Kvartalsrapport 2017-Q3 |
| 2017-08-31 | - | Kvartalsrapport 2017-Q2 |
| 2017-05-11 | - | X-dag ordinarie utdelning CHOSA 0.00 SEK |
| 2017-05-10 | - | Årsstämma |
| 2017-05-10 | - | Kvartalsrapport 2017-Q1 |
| 2017-02-09 | - | Bokslutskommuniké 2016 |
| 2017-01-10 | - | Extra Bolagsstämma 2017 |
| 2016-10-27 | - | Kvartalsrapport 2016-Q3 |
| 2016-08-31 | - | Kvartalsrapport 2016-Q2 |
| 2016-05-10 | - | Årsstämma |
| 2016-05-10 | - | Kvartalsrapport 2016-Q1 |
Beskrivning
| Land | Sverige |
|---|---|
| Lista | Spotlight |
| Sektor | Hälsovård |
| Industri | Bioteknik |
The Swedish Companies Registration Office has registered the name change from RhoVac AB to CHOSA Oncology AB. The company's shares will therefore be traded under the new name CHOSA Oncology AB on Spotlight Stock Market. The new ticker will be CHOSA.
On 11 January 2023, an Extraordinary General Meeting in RhoVac AB was held. The General Meeting resolved to approve the Board of Directors' proposal to approve the acquisition of CHOSA ApS and change the company's name to CHOSA Oncology AB. The new name has now been registered by the Swedish Companies Registration Office. The company's shares will from 15 February 2023 be traded under the new name CHOSA Oncology AB (ticker: CHOSA). The ISIN code will not change and will thus remain SE0007784319. The FISN code will be changed to CHOSAON/SH.
Following the new name, the company's website where financial information, regulatory press releases and other investor-related information will be published, will change to www.chosaoncology.com
As previously communicated, the General Meeting also resolved to change the company's board and management. Peter Buhl Jensen has now taken office as the company's CEO, and Neil Goldsmith (Chairman), Ulla Hald Buhl, Claus Frisenberg and Ingrid Atteryd Heiman now constitute the company's Board of Directors, together with the previous board member Lars Hedbys.
Peter Buhl Jensen, CEO
peter@chosa.bio
+ 45 21 60 89 22